Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Chronic Liver Disease”

102 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 102 results

Testing effectiveness (Phase 2)Study completedNCT03111732
What this trial is testing

Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC)

Who this might be right for
Biliary Tract NeoplasmsCholangiocarcinomaBile Duct Cancer+2 more
National Cancer Institute (NCI) 11
Not applicableUnknownNCT02653846
What this trial is testing

Correlation of Liver and Spleen Stiffness by RT-2D-SWE and Severity of Portal Hypertension by HVPG

Who this might be right for
Chronic Liver Diseases
University Hospital Dubrava 50
Post-approval studies (Phase 4)UnknownNCT03798119
What this trial is testing

TAF Switch in F3/4 CHB pt With Partial Response to NUC (ESTAB-AFPVR)

Who this might be right for
Hepatitis BFibrosis and Cirrhosis of Liver
Kaohsiung Medical University Chung-Ho Memorial Hospital 80
Early research (Phase 1)Study completedNCT00049400
What this trial is testing

S0355 Ixabepilone in Treating Patients With Advanced Solid Tumors or Lymphomas and Liver Dysfunction

Who this might be right for
LymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific
SWOG Cancer Research Network 78
Testing effectiveness (Phase 2)Study completedNCT05663944
What this trial is testing

REpurposing SirolimUS in Compensated Advanced Chronic Liver Disease. the RESUS Proof of Concept Study

Who this might be right for
Advanced Chronic Liver Disease
Nottingham University Hospitals NHS Trust 41
Large-scale testing (Phase 3)UnknownNCT06434753
What this trial is testing

Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease.

Who this might be right for
Advanced Chronic Liver DiseasePortal HypertensionHepatocellular Carcinoma
Hospital Universitari Vall d'Hebron Research Institute 300
Not applicableStudy completedNCT05097963
What this trial is testing

Evaluate Liver Stiffness With Shear Wave Elastography

Who this might be right for
Chronic Liver DiseaseAdvanced FibrosisAdvanced Cirrhosis
Mayo Clinic 63
Not applicableNot Yet RecruitingNCT07777198
What this trial is testing

Liver Stiffness Changes by iLivTouch to Predict Liver-Related Events in MAFLD

Who this might be right for
MAFLD
Beijing Friendship Hospital 2,303
Not applicableLooking for participantsNCT06971848
What this trial is testing

Evaluation of Skin Tests in Biotherapy Allergies

Who this might be right for
Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and NeckMelanoma NeoplasmsSmall Cell Bronchial Carcinomas+13 more
University Hospital, Angers 70
Post-approval studies (Phase 4)Looking for participantsNCT06449339
What this trial is testing

Non-selective Beta-blocker in Compensated Advanced Chronic Liver Disease

Who this might be right for
Portal HypertensionHepatic DecompensationAdvanced Chronic Liver Disease
Chinese University of Hong Kong 474
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT00608361
What this trial is testing

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery

Who this might be right for
Adult Acute Lymphoblastic Leukemia in RemissionAdult B Acute Lymphoblastic LeukemiaAdult Hepatocellular Carcinoma+82 more
National Cancer Institute (NCI) 80
Not applicableLooking for participantsNCT06523608
What this trial is testing

Prediction of Decompensation and HCC Development in Advanced Chronic Liver Disease

Who this might be right for
Liver DiseasesHepatocellular CarcinomaHepatocarcinoma+1 more
University Hospital Muenster 600
Large-scale testing (Phase 3)Study completedNCT02319031
What this trial is testing

Safety and Efficacy Study of the Combination Daclatasvir (60 mg), Sofosbuvir (400 mg) and Ribavirin (Weight-based Dosing) for 12 or 16 Weeks in Subjects With Genotype 3 Chronic HCV Infection With or Without Prior Treatment Experience and Advanced Fibrosis or Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 53
Not applicableNot Yet RecruitingNCT07764835
What this trial is testing

Prospective Evaluation of Hepatocellular Carcinoma Surveillance in At-Risk Patients (Screening HCC)

Who this might be right for
Hepatocellular CarcinomaLiver CirrhosisChronic Hepatitis B+2 more
D'Or Institute for Research and Education 300
Post-approval studies (Phase 4)WithdrawnNCT02206932
What this trial is testing

The Safety and Effectiveness of Simeprevir and Sofosbuvir for Patients With HIV and Hepatitis C

Who this might be right for
Hepatitis C, ChronicHIV CDC Category A1
University of California, San Francisco
Testing effectiveness (Phase 2)Study completedNCT00006016
What this trial is testing

Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by Surgery

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer
National Cancer Institute (NCI) 75
Not applicableUnknownNCT04975477
What this trial is testing

CHESS-SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102)

Who this might be right for
Compensated Advanced Chronic Liver Disease
Hepatopancreatobiliary Surgery Institute of Gansu Province 1,000
Testing effectiveness (Phase 2)UnknownNCT05542615
What this trial is testing

Prolonged Release Pirfenidone for Advanced Residual Liver Fibrosis (MINERVA).

Who this might be right for
Liver CirrhosisHepatitis C, ChronicEpigenetic Disorder
University of Guadalajara 60
Early research (Phase 1)Study completedNCT06973005
What this trial is testing

Investigate How Multiple Oral Doses of AZD2389 Affect the Pharmacokinetics of Midazolam, Caffeine, and Bupropion in Healthy Participants

Who this might be right for
Advanced Chronic Liver DiseaseHealthy Participants
AstraZeneca 16
Next Page